Atrium Therapeutics, Inc. (RNA) Dividend Yield, History & Forecast
Atrium Therapeutics, Inc. (RNA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $209M.
Frequently Asked Questions about Atrium Therapeutics, Inc. (RNA)
Is Atrium Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Atrium Therapeutics, Inc. in?▾
Atrium Therapeutics, Inc. (RNA) operates in the Healthcare sector, specifically the Biotechnology industry.
